Do the histologic features and results of breast cancer biomarker studies differ between core biopsy and surgical excision specimens?
- 1 April 2006
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 15 (2) , 167-172
- https://doi.org/10.1016/j.breast.2005.06.004
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancerWiener klinische Wochenschrift, 2004
- Reporting needle core biopsies of breast carcinomasHistopathology, 2003
- Correlation of Histologic Prognostic Factors in Core Biopsies and Therapeutic Excisions of Invasive Breast CarcinomaThe American Journal of Surgical Pathology, 2003
- A comparison of prognostic tumor markers obtained on image-guided breast biopsies and final surgical specimensThe American Journal of Surgery, 2002
- Comparison of core oestrogen receptor (ER) assay with excised tumour: intratumoral distribution of ER in breast carcinomaJournal of Clinical Pathology, 2001
- Immunohistochemical determination of her2 expression in breast cancer from core biopsy specimens: a reliable predictor of her2 status of the whole tumorBreast Cancer Research and Treatment, 2001
- Oestrogen and progesterone receptor assessment in core biopsy specimens of breast carcinoma.Journal of Clinical Pathology, 1997
- Critical determination of the frequency of c-erbB-2 amplification in breast cancerBritish Journal of Cancer, 1994
- pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long‐term follow‐upHistopathology, 1991
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987